Current Cardiology Reports

, 20:133 | Cite as

Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes

  • H. Vernon AndersonEmail author
  • Robin Jacob
Management of Acute Coronary Syndromes (H Jneid, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Management of Acute Coronary Syndromes


Purpose of Review

This review summarizes and discusses the evidence base supporting current performance and quality measures used in assessing institutions in their care of patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS).

Recent Findings

Professional societies in the USA and Europe have developed performance and quality measures for NSTE-ACS. These measures are reviewed and updated periodically to reflect the most important evidence from the literature. In the USA, the ACC/AHA Task Force on Performance Measures published the updated 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction. In Europe, the ESC Acute Cardiac Care Association published the 2017 Quality Indicators for acute myocardial infarction. These documents build on guidelines previously developed and published by the two organizations. They include detailed reviews of current and past studies establishing that adherence with guidelines improves clinical outcomes. Both measure sets provide quantitative methodologies to assess program performance. Institutional programs that focus on these validated measures can increase guideline adherence, streamline and standardize care processes, and reduce morbidity and mortality.


Performance and quality measures have become a critical part of healthcare today, allowing patients, providers, administrators, and payors to assess patient care objectively. They are also becoming an important component of value-based payment programs. To be fair, and useful, for internal institutional assessment, in comparing different institutions, and for value-based payments, only validated performance measures such as these should be employed.


Quality measures Performance measures Non-ST segment elevation acute coronary syndromes 



American College of Cardiology


ACC/AHA Task Force on Performance Measures




Acute coronary syndrome


American Heart Association


Acute myocardial infarction


Angiotensin receptor blocker


Coronary artery bypass surgery


Dual antiplatelet therapy


European Society of Cardiology


Get with the Guidelines-Coronary Artery Disease Program


Left ventricular systolic dysfunction


National Cardiovascular Data Registries


Non-ST segment elevation-acute coronary syndrome


Non-ST segment elevation myocardial infarction


Percutaneous coronary intervention


Performance measures


Quality measures


ST segment elevation myocardial infarction


Unstable angina


Compliance with Ethical Standards

Conflict of Interest

H. Vernon Anderson and Robin Jacob declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • AHA Heart and Stoke Facts 2018. Circulation. 2018;137:e67–e492. Contemporary US cardiovascular data.
  2. 2.
    Mendis S, Puska P, Norrving B, editors. Global atlas on cardiovascular disease prevention and control: World Health Organization; 2011. –Geneva. Available at: Accessed July 12, 2018
  3. 3.
    Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–57. Scholar
  4. 4.
    Crea F, Liuzzo G. Pathogenesis of acute coronary syndromes. J Am Coll Cardiol. 2013;61:1–11. Scholar
  5. 5.
    • Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics 2017. Brussels: European Heart Network; 2017. Available at: Accessed July 12, 2018. Contemporary European cardiovascular data. Google Scholar
  6. 6.
    Crea F, Binder RK, Lüscher TF. The year in cardiology 2017: acute coronary syndromes. Eur Heart J. 2018;39:1054–64. Scholar
  7. 7.
    • Braunwald E, Morrow DA. Unstable angina: is it time for a requiem? Circulation. 2013;127:2452–7. Reviews the changing proportions of ACS subtypes. CrossRefPubMedGoogle Scholar
  8. 8.
    •• Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2014;64:e139–228. Contains the most recently updated US NSTEACS guidelines. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    •• Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37:267–315. Contains the most recently updated European NSTEACS guidelines. CrossRefPubMedGoogle Scholar
  10. 10.
    Rodriguez F, Mahaffey KW. Management of patients with NSTE-ACS: a comparison of the recent AHA/ACC and ESC guidelines. J Am Coll Cardiol. 2016;68:313–21. Scholar
  11. 11.
    Available at: Accessed July 12, 2018.
  12. 12.
    TIMI Study Group. Available at: Accessed July 12, 2018.
  13. 13.
    Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–87.CrossRefGoogle Scholar
  14. 14.
    • Elgendy IY, Kumbhani DJ, Mahmoud AN, Wen X, Bhatt DL, Bavry AA. Routine invasive versus selective invasive strategies for non-ST-elevation acute coronary syndromes: an updated meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2016;88:765–74. Established the routine invasive strategy in NSTEACS as superior. CrossRefPubMedGoogle Scholar
  15. 15.
    Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management. J Am Coll Cardiol. 2010;55:1416–24. Scholar
  16. 16.
    •• Milosevic A, Vasiljevic-Pokrajcic Z, Milasinovic D, Marinkovic J, Vukcevic V, Stefanovic B, et al. Immediate versus delayed invasive intervention for non-ST-segment elevation myocardial infarction patients. J Am Coll Cardiol Intv. 2016;9:541–9. Small study suggesting that immediate (<2 hours) invasive strategy is superior in NSTEACS. CrossRefGoogle Scholar
  17. 17.
    Peterson ED, Roe MT, Mulgund J, DeLong ER, Lytle BL, Brindis RG, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295:1912–20.CrossRefGoogle Scholar
  18. 18.
    Thukkani AK, Fonarow GC, Cannon CP, Cox M, Hernandez AF, Peterson ED, et al. Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: insights from get with the guidelines-CAD. Clin Cardiol. 2014;37:285–92. Scholar
  19. 19.
    Simms AD, Batin PD, Weston CF, Fox KA, Timmis A, Long WR, et al. An evaluation of composite indicators of hospital acute myocardial infarction care: a study of 136,392 patients from the Myocardial Ischaemia National Audit Project. Int J Cardiol. 2013;170:81–7. Scholar
  20. 20.
    Simms AD, Baxter PD, Cattle BA, Batin PD, Wilson JI, West RM, et al. An assessment of composite measures of hospital performance and associated mortality for patients with acute myocardial infarction. Analysis of individual hospital performance and outcome for the National Institute for Cardiovascular Outcomes Research (NICOR). Eur Heart J Acute Cardiovasc Care. 2013;2:9–18. Scholar
  21. 21.
    Mathews R, Wang W, Kaltenbach LA, Thomas L, Shah RU, Ali M, et al. Hospital variation in adherence rates to secondary prevention medications and the implications on quality. Circulation. 2018;137:2128–38. Scholar
  22. 22.
    Pinho-Gomes AC, Azevedo L, Ahn JM, Park SJ, Hamza TH, Farkouh ME, et al. Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials. J Am Coll Cardiol. 2018;71:591–602. Scholar
  23. 23.
    Kulik A, Ruel M, Jneid H, Ferguson TB, Hiratzka LF, Ikonomidis JS, et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation. 2015;131:927–64.CrossRefGoogle Scholar
  24. 24.
    Van de Werf F, Ardissino D, Bueno H, Collet JP, Gershlick A, Kolh P, et al. Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines. Expert Rev Cardiovasc Ther. 2012;10:489–503. Scholar
  25. 25.
    Wessler JD, Stant J, Duru S, Rabbani L, Kirtane AJ. Updates to the ACCF/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice. Am J Cardiol. 2015;115(Suppl):23A–8A. Scholar
  26. 26.
    Shah AP, Nathan S. Challenges in implementation of institutional protocols for patients with acute coronary syndrome. Am J Cardiol. 2018;122:356–63. Scholar
  27. 27.
    Putera M, Roark R, Lopes RD, Udayakumar K, Peterson ED, Califf RM, et al. Translation of acute coronary syndrome therapies: from evidence to routine clinical practice. Am Heart J. 2015;169:266–73. Scholar
  28. 28.
    Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. J Am Coll Cardiol. 2001;38:2114–30.CrossRefGoogle Scholar
  29. 29.
    Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand SL. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45:1147–56.CrossRefGoogle Scholar
  30. 30.
    Krumholz HM, Anderson JL, Brooks NH, Fesmire FM, Lambrew CT, Landrum MB, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing committee to develop performance measures on ST-elevation and non-ST-elevation myocardial infarction). J Am Coll Cardiol. 2006;47:236–65.CrossRefGoogle Scholar
  31. 31.
    Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction). Developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians. J Am Coll Cardiol. 2008;52:2046–99.CrossRefGoogle Scholar
  32. 32.
    •• Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, et al. 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70:2048–90. Contains the most recently updated US performance metrics for assessing care of patients with NSTEACS. CrossRefPubMedGoogle Scholar
  33. 33.
    •• Schiele F, Gale CP, Bonnefoy E, Capuano F, Claeys MJ, Danchin N, et al. Quality indicators for acute myocardial infarction: a position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2017;6:34–59. Contains the most recently updated European performance metrics for assessing care of patients with MI, including those with NSTEACS. CrossRefPubMedGoogle Scholar
  34. 34.
    • Jneid H, Bozkurt B, Fonarow GC. The 2017 AHA/ACC performance and quality measures for patients with acute myocardial infarction. JAMA Cardiol. 2018;3:659–60. A short overview of the most recently updated US performance metrics. CrossRefGoogle Scholar
  35. 35.
    NCDR. Chest Pain - MI registry. Available at: Accessed September 9, 2018.
  36. 36.
  37. 37.
    •• MacLean CH, Kerr EA, Qaseem A. Time out - charting a path for improving performance measurement. N Engl J Med. 2018;378:1757–61. Reviews the validity of performance and quality metrics in current use. CrossRefPubMedGoogle Scholar
  38. 38.
    Klein LW, Harjai KJ, Resnic F, Weintraub WS, Anderson HV, Yeh RW, et al. 2016 Revision of the SCAI position statement on public reporting. Catheter Cardiovasc Interv. 2017;89:269–79. Scholar
  39. 39.
    Heidenreich PA. In pursuit of better measures of quality of care. JAMA Cardiol. 2018;3:553–4. Scholar
  40. 40.
    Iezzoni LI. 100 apples divided by 15 red herrings: a cautionary tale from the mid-19th century on comparing hospital mortality rates. Ann Intern Med. 1996;124:1079–85.CrossRefGoogle Scholar
  41. 41.
    Iezzoni LI. The risks of risk adjustment. JAMA. 1997;278:1600–7.CrossRefGoogle Scholar
  42. 42.
    Shahian DM, Wolf RE, Iezzoni LI, Kirle L, Normand SL. Variability in the measurement of hospital-wide mortality rates. N Engl J Med. 2010;363:2530–9. Scholar
  43. 43.
    • Thomas JW, Hofer TP. Accuracy of risk-adjusted mortality rate as a measure of hospital quality of care. Med Care. 1999;37:83–92. Reviews the accuracy of risk-adjusted mortality as a quality measure. CrossRefGoogle Scholar
  44. 44.
    Fischer C, Steyerberg EW, Fonarow GC, Ganiats TG, Lingsman HF. A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure. Am Heart J. 2015;170:1005–1017.e2. Scholar
  45. 45.
    Pandey A, Golwala H, Hall HM, Wang TY, Lu D, Xian Y, et al. Association of US Centers for Medicare and Medicaid Services hospital 30-day risk-standardized readmission metric with care quality and outcomes after acute myocardial infarction. JAMA Cardiol. 2017;2:723–31. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Cardiology DivisionUniversity of Texas Health Science Center, McGovern Medical School, Memorial Hermann Heart & Vascular InstituteHoustonUSA

Personalised recommendations